HDFC Mutual Fund increases stake in Piramal Pharma

HDFC Mutual Fund has disclosed an increase in its stake in Piramal Pharma Limited. According to a filing made under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, the aggregate holding of schemes of HDFC Mutual Fund in Piramal Pharma has increased by 1.997% since the last disclosure on July 30, 2024. As of June 26, 2025, the fund now holds 120,082,126 equity shares, representing 9.034% of the company's paid-up equity share capital, which is valued at INR 13,292,481,300 comprising 132,924,813 equity shares of INR 10 each. The acquisition of shares, made through open market purchases, has been duly reported to the National Stock Exchange of India and BSE Limited.